Your Search Returned 2 tagged news reports
Renal denervation has shown promise in treating severe drug-resistant hypertension and, by the company's estimates, the global market opportunity for renal denervation is approaching $30 billion. The company's V2 renal denervation system is
Tags:
Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today that it will make its first detailed public presentation of preclinical data relating to its new V2 Renal Denervation System on
Tags: